Adherence to stimulants in adult ADHD

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 6, Issue 2, 2014, Pages 111-120

  O’Callaghan, Pamela ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adherence compliance; Attention deficit hyperactivity disorder (ADHD); Patient provider relationships; Quality of life

Indexed keywords

CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONCURRENT VALIDITY; DISEASE SEVERITY; FEMALE; HEALTH BELIEF MODEL; HEALTH CARE PERSONNEL; HUMAN; IMPULSIVENESS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCHOOL CHILD; SCORING SYSTEM; SELF CONCEPT; SEMI STRUCTURED INTERVIEW; SHORT FORM 36; THEMATIC ANALYSIS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOCTOR PATIENT RELATION; MEDICATION COMPLIANCE; PSYCHOLOGY; YOUNG ADULT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; SELF EFFICACY; YOUNG ADULT;

EID: 84908118541     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-014-0129-y     Document Type: Article

References (56)

1. Able S, Johnston J, Adler L, Swindle R (2007) Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37:97–107
2. Adler L, Spencer T, Williams D, Moore R, Michelson D (2008) Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. J Atten Disord 12:248–253
3. Agarwal R, Goldenberg M, Perry R, Ishak W (2012) The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innov Clin Neurosci 9:10–21
4. Aikens J, Nease D, Klinkman M (2008) Explaining patients’ beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med 6:23–29
5. Barkley R, Murphy K, Fischer M (2008) ADHD in adults: what the science says. The Guilford Press, New York
6. Berger B, Felkey B (2001) Improving patient compliance. impact U.S. pharmacist continuing education series June 1–12 U.S. Pharmacist, Bridgewater, NJ
7. Biederman J, Mick E, Fried R, Aleardi M, Potter A, Herzig K (2005) A simulated workplace experience for non-medicated adults with and without ADHD. Psychiatry Serv 56:1617–1620
8. Biederman J, Faraone S, Spencer T, Mick E, Monuteaux M, Aleardi M (2006) Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 67:524–540
9. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Michel E, Martin J, Spencer T (2007) Comparative acute efficacy and tolerability of OROS and immediate release formulations of methyphenidae in the treatment of adults with attention-deficit/hyperactivity disorder. BMC Psychiatry 7:49–57
10. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101
11. Brod M, Perwien A, Adler L, Spencer T, Johnston J (2005) Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder. Prim Psychiatry 12:58–64
12. Brod M, Johnston J, Able S, Swindle R (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale: a disease-specific quality-of-life measure. Qual Life Res 15:117–129
13. Brunt K, Matza L, Classi P, Johnston J (2011) Preference related to attention-deficit/hyperactivity disorder and its treatment. Patient Prefer Adherence 5:33–43
14. Charach A, Fernandez R (2013) Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep. doi:10.1007/s11920-013-0371-6
15. Crabtree B, Miller W (1999) A template approach to text analysis: developing and using codebooks. In: Crabtree B, Miller W (eds) Doing qualitative research. Sage Publishing, Thousand Oaks, pp 163–177
16. Cramer J (1991) Overview of methods to measure and enhance patient compliance. In: Cramer J, Spilker B (eds) Patient compliance in medical practice and clinical trials. Raven Press, New York, pp 3–10
17. Crawford P, Gilbert P, Gilbert J, Gale C, Harvey K (2013) The language of compassion in acute mental health care. Qual Health Res 23:719–727
18. Curtis F, Fairman K (2007) ADD or ADHD or what exactly?—GIGO part II and other lessons in research with administrative claims. J Manag Care Pharm 13:617–619
19. Escobar R, Schacht A, Wehmeier P, Wagner T (2010) Quality of life and attention-deficit/hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J Clin Psychopharmacol 30:145–151
20. Faraone S, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36:159–165
21. Fereday J, Muir-Cochrane E (2006) Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods 5. http://ejournals.library.ualberta.ca/index.php/IJQM/article/view/4411. Accessed 11 January 2013
22. Findling R, Connor D, Wigal T, Eagan C (2009) A linguistic analysis of in-office dialogue among psychiatrists, parents, and child and adolescent patients with ADHD. J Atten Disord 13:78–86
23. Fleischmann A, Fleischmann R (2012) Advantage of an ADHD diagnosis in adulthood: evidence from online narratives. Qual Health Res 22:1486–1496
24. Glanz K, Rimer B (2005) Theory at a glance: a guide for health promotion practice. National Cancer Institute, National Institutes of Health, 2nd edn. U.S. Department of Health and Human Services, Washington, DC
25. Gudjonsson G, Sigurdsson J, Eyjolfsdottir G, Smair J, Young S (2009) The relationship between satisfaction with life, ADHD symptoms, and associated problems among university students. J Atten Disord 12:507–515
26. Hodgkins P, Boken M, Capone N, Deleon A (2006) Office visits and prescription fill rates in patients with ADHD. U.S. Psychiatric and Mental Health Congress, Abstract 122, November 2006, New Orleans, Louisiana
27. Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 27:555–567
28. Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14:1–24
29. Ivankova N, Creswell J, Stick S (2006) Using mixed-methods sequential explanatory design: from theory to practice. Field Methods 18:3–20
30. Jadad A, Boyle M, Cunningham C, Kim M, Schachar R (1999) Treatment of attention-deficit/hyperactivity disorder. Evidence Report/Technology Assessment No. 11 Prepared by McMaster University under Contract No. 290-97-0017 AHRQ Publication No. 00-E005 Agency for Healthcare Research and Quality, Rockville, MD
31. Janz N, Becker M (1984) The health belief model: a decade later. Health Educ Q 11:1–47
32. Jonsdottir H, Friis S, Horne R, Pettersen K, Reikvam A (2009) Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand 119:78–84
33. Kessler R, Adler L, Barkley R, Biederman J, Conners K, Demler O, Faraone S, Greenhill L, Howes M, Secnik K, Spencer T, Ustun T, Walters E, Zaslavsky A (2006) The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatr 163:716–723
34. Kramer J, Hammill B, Anstrom K, Fetteroff D, Snyder R, Charde J, Hoffman B, LaPointe N, Peterson E (2006) National evaluation of adherence to (Beta) blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J 152:454.e1–454.e8
35. Lowen B, Rosen J, Marttila J (2011) An agenda for improving compassionate care: a survey shows about half of patients say such care is missing. Health Aff 30:1772–1778
36. Matza L, Johnston J, Faries D, Malley K, Brod M (2007) Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res 16:1511–1520
37. Montoya A, Quail D, Anand E, Cardo E, Alda J, Escobar R (2013) Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis. Atten Defic Hyperact Disord. doi:10.1007/s12402-013-0119-5
38. Morris L, Schulz R (1992) Patient compliance: an overview. J Clin Pharm Ther 17:183–195
39. Munro S, Lewin S, Swart T, Volmink J (2007) A review of health behavior theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 7:1–16
40. Olfson M, Marcus S, Zhang H, Wan G (2007) Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm 13:570–577
41. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497
42. Perwien A, Hall J, Swensen A, Swindle R (2004) Stimulant treatment patterns and compliance in children and adults with newly treated ADHD. J Manag Care Pharm 10:122–129
43. Pope C, Ziebland S, Mays N (2000) Qualitative research in health care: analyzing qualitative data. Br Med J 320:114–116
44. Rafalovich A (2005) Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder. Sociol Health Illn 27:305–323
45. Ramsay J, Rostain A (2008) Adult ADHD research: current status and future directions. J Atten Disord 11:624–627
46. Roberson M (1992) The meaning of compliance: patient perspectives. Qual Health Res 2:7–26
47. Rostain A, Ramsey J (2006) A combined treatment approach for adults with ADHD—results of an open study of 43 patients. J Atten Disord 10:150–159
48. Safren S, Duran P, Yovel I, Perlman C, Sprich S (2007) Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord 10:257–260
49. Serradell J, Litman T, Hendel D, Hadsall R (1990) Patients’ perception in provision of information and drug defaulting behavior. Pharmacy 1:35–46
50. Stern A, Pollak Y, Bonne O, Malik E, Maeir A (2013) The relationship between executive functions and quality of life in adults with ADHD. J Atten Disord. doi:10.1177/1087054713504133
51. Torgersen R, Gjervan B, Rasmussen K (2008) Treatment of adult ADHD: is current knowledge useful to clinicians? Neuropsychiatr Dis Treat 4:177–186
52. Vermeire E, Hearnshaw H, Van Royen P (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm 26:331–342
53. Weisler R, Goodman D (2007) Understanding adult ADHD: treatment adherence and rationale for treatment selection. Psychiatric Times Reporter, pp 2–5
54. Weisler R, Biederman J, Spencer T, Wilens T, Faraone S, Chrisman A, Read S, Tulloch S (2006) Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 11:625–639
55. Weiss M, Hechtman L, Weiss G (1999) AD/HD in adulthood. Johns Hopkins University Press, Baltimore
56. Weiss M, Gadow K, Wasdell M (2006) Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67:38–45